The "French Paradox" - Effects of alcohol, wine and wine polyphenols on the heart;Das "French Paradox" - Wirkungen von alkohol, wein und weininhaltsstoffen auf das Herz

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 51-52, 2002, Pages 2748-2756

  Bohm M ^a   Rosenkranz, S ^b   Laufs, U ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; POLYPHENOL DERIVATIVE;

ALCOHOL CONSUMPTION; ARTICLE; HEART FUNCTION; WINE;

ALCOHOL DRINKING; DIET; ETHANOL; EUROPE; FLAVONOIDS; FRANCE; HEART; HUMANS; PHENOLS; POLYMERS; WINE;

EID: 0037147399     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36275     Document Type: Article

References (53)

1. Bingen H. Causae et Curae. Therapeutische Monatshefte, 16. Jahrgang, Berlin, Übersetzung Dr. phil. Kaiser. 1902
2. Bollinger. Über die häufigkeit und ursachen der idiopathischen herzhypertrophie in München. Dtsch Med Wochenschr 1884; 12
3. Camacho TC, Kaplan GA, Cohen RD. Alcohol consumption and mortality in Alameda county. J Chronic Dis 1987; 40: 229-236
4. Criqui MH, Ringel BL. Does diet or alcohol explain the French Paradox. Lancet 1994; 344: 1719-1723
5. De Lorgeril M, Salen P, Marin JL, Boucher F, Paillard F, de Leiris J. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 2002; 106: 1465-1469
6. De Oliveira E, Silva ER, Foster D, McGee HM, Seidman CE, Smith JD, Breslow JL. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000; 102: 2347-2352
7. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105: 2836-2844
8. Dyer AR, Stamler J, Paul O, Berkson DM, Lepper MH, Shekelle RB, McKean H, Garside D. Alcohol consumption and 17-year mortality in the Chicago western electric company study. Rev Med 1980; 9: 78-90
9. Flesch M, Erdmann E, Böhm M. Alkohol und myokardinfarkt, epidemiologische und experimentelle untersuchungen zum einfluss von alkohol auf gefäβrelaxation und koronarsklerose. Dtsch Med Wochenschr 1998; 123: 1490-1496
10. Flesch M, Schwarz A, Böhm M. Different effects of red and white wine on endothelial-dependent vasorelaxation of coronary arteries. Am J Physiol 1998; 1998: H1183-H1190
11. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457
12. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women: The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99
13. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986; 124: 481-489
14. Fuchs CS, Stampfer MJ, Golditz GA, Giovanucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens C, Rosner B, Speizer FD, Willet WC. Alcohol consumption and mortality among women. N Engl J Med 1995; 332: 1245-1250
15. Garfinkel L, Bofetta P, Stellman S. Alcohol and breast cancer: A cohort study. Prev Med 1988; 17: 686-693
16. Gaziano JM, Buring JE, Breslow JL, Goldhaber SU, Rosner B, van Denburgh M, Willet W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-1834
17. Goldberg U, Mosca L, Piano MR, Fisher EA. Wine and your heart: A science advisory for healthcare professionals from the nutrition committee, council on epidemiology and prevention, and council on cardiovascular nursing of the American Heart Association. Circulation 2001; 103: 472-475
18. Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000; 19: 411-419
19. Gronbaek M, Dies A, Sorensen TIA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995; 310: 1165-1169
20. Hart CE. PDGF β receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 1999; 99: 564-569
21. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, Sacks F, Rimm EB, Hunter DJ. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001; 344: 549-555
22. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130: 53-56
23. Keil U, Chambless LE, Doring A, Filipiak B, Stieber J. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer drinking population. Epidemiology 1997; 8: 150-156
24. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383-389
25. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992; 117: 646-654
26. Klatsky Al, Friedman GD, Siegelaub AB. Alcohol use and cardiovascular disease: The Kaiser-Permanente experience. Circulation 1981; 64: 32-41
27. Leikert JF, Räthel TR, Wohlfart P, Chéynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002; 106: 1614-1617
28. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: Meta-analysis and review. Cancer Causes Control 1994; 5: 73-82
29. Lowenstein SR, Gabow PA, Cramer J, Oliva PD, Ratner K. The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 1983; 143: 1882-1885
30. Luis AJ. Atherosclerosis. Ature 2000; 407: 233-241
31. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994; 344: 193-194
32. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ 1979; 1: 153-156
33. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 2001; 285: 1965-1970
34. National Center for Health Statistics. Vital Statistics of the United States: Mortality Series, Washington, D. C.Government Printing Office, 1968-1988
35. Nishikawa M, Ishikawa T, Ito T, Shige H, Tomiyasu K, Nakajima K, Kondo K, Hashimoto H, Saitoh K, Manabe M. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: Cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis 1994; 111: 99-109
36. Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol cirrhosis in women. BMJ 1987; 295: 8082
37. Pace-Asiak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block huma platelet aggregation and eicosanoid synthesis. Implications for protection against coronary heart disease. Clinica Chemica Acta 1995; 235: 207-219
38. Renaud SG, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: The Caerphilly prospective heart disease study. Am J Clin Nutr 1992; 55: 1012-1017
39. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526
40. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentrations of endogenous tissue-typ plasminogen activator. JAMA 1994; 27: 929-933
41. Rimm EB, Giovannucci EL, Willet WC, Golditz GA, Ascherioi A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468
42. Rimm EB, Stampfer MJ. Wine, beer, and spirits. Are they really horses of a different color? Circulation 2002; 105: 2806-2807
43. Rogers S, Yarnell JWG, Fehily AM. Nutritional determinants of haemostatic factors ii the Caerphilly study. Eur J Clin Nutr 1988; 42: 197-205
44. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Böhm M. Inhibition of the PDGF receptor by red wine flaonoids provides a molecular explanation for the "French paradox". FASEB J 2002; 16: 1958-1960
45. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-126
46. Sano H. Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 2001; 103: 2955-2960
47. Schipperges H. Moderne Medizin im Spiegel der Geschichte. Thieme, Stuttgart, 1970: 124
48. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: Explaining the U-shaped curve. Lancet 1988; 2: 1267-1273
49. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary flow-velocity reserve. Lancet 1999; 354: 1002
50. Solomon CG, Hu FB, Stampfer MJ, Golditz GA, Speizer FE, Rimm EB, Willert WC, Manson JE. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000; 102: 494-499
51. Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H, Chayama K. Effet of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 2002; 165: 145-152
52. Truelsen T, Gronbaek M, Schnohr P, Boysen G. Intake of beer, wine, and spirits and risk of stroke: The copenhagen city heart study. Stroke 1998; 29: 2467-2472
53. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106: 1652-1658